Research
New study identifies biological mechanism driving therapy resistance in advanced prostate cancer
The Brief
- A multi-institutional study led by the University of Chicago and Fred Hutchinson Cancer Center identified a previously unknown biological mechanism.
- The mechanism controls cell identity and treatment resistance in advanced prostate cancer.
- The source reports the finding from a study; no further details on treatments or trial results are given in the provided material.
Why it matters
Understanding how prostate cancer cells resist therapy could point to new drug targets, though the finding is at an early research stage.
- #prostate cancer
- #therapy resistance
- #cancer biology
- #cell identity
A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment resistance in advanced prostate cancer.
Timeline
Medical Xpress reports the study identifying the mechanism
Medical Xpress - latest medical and health news stories
New study identifies biological mechanism driving therapy resistance in advanced prostate cancer